Short Interest in Vivos Inc. (OTCMKTS:RDGL) Increases By 3,052.4%

Vivos Inc. (OTCMKTS:RDGL) was the target of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 198,600 shares, an increase of 3,052.4% from the October 31st total of 6,300 shares. Based on an average daily trading volume, of 3,248,800 shares, the short-interest ratio is currently 0.1 days.

Vivos Stock Performance

OTCMKTS:RDGL opened at $0.09 on Thursday. The stock has a market cap of $39.12 million, a price-to-earnings ratio of -9.10 and a beta of 1.07. Vivos has a 1 year low of $0.05 and a 1 year high of $0.26. The business has a fifty day moving average of $0.14 and a 200-day moving average of $0.15.

About Vivos

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.